Downregulation of microRNA-29 by antisense inhibitors and a PPAR-γagonist protects against myocardial ischaemia-reperfusion injury

Yumei Ye, Zhaoyong Hu, Yu Lin, Congfang Zhang, Jose R. Perez-Polo

Research output: Contribution to journalArticle

146 Citations (Scopus)

Abstract

AimsMicroRNAs (miRNAs) regulate various cardiac processes including cell proliferation and apoptosis. Pioglitazone (PIO), a peroxisome proliferator-activated receptor (PPAR)-agonist, protects against myocardial ischaemia-reperfusion (IR) injury. We assessed the effects of PPAR-activation on myocardial miRNA levels and the role of miRNAs in IR injury.Methods and resultsWe evaluated the expression changes of miRNAs in the rat heart after PIO administration using miRNA arrays and then confirmed the result by northern blot. miR-29a and c levels decreased remarkably after 7-day treatment with PIO. In H9c2 cells, the effects of PIO and rosiglitazone on miR-29 expression levels were blocked by a selective PPAR-inhibitor GW9662. Downregulation of miR-29 by antisense inhibitor or by PIO protected H9c2 cells from simulated IR injury, indicated as increased cell survival and decreased caspase-3 activity. In contrast, overexpressing miR-29 promoted apoptosis and completely blocked the protective effect of PIO. Antagomirs against miR-29a or-29c significantly reduced myocardial infarct size and apoptosis in hearts subjected to IR injury. Western blot analyses demonstrated that Mcl-2, an anti-apoptotic Bcl-2 family member, was increased by miR-29 inhibition.ConclusionDownregulation of miR-29 protected hearts against IR injury. The modulation of miRNAs can be achieved by pharmacological intervention. These findings provide a rationale for the development of miRNA-based strategies for the attenuation of IR injury.

Original languageEnglish (US)
Pages (from-to)535-544
Number of pages10
JournalCardiovascular Research
Volume87
Issue number3
DOIs
StatePublished - 2010

Fingerprint

pioglitazone
Myocardial Reperfusion Injury
Peroxisome Proliferator-Activated Receptors
Reperfusion Injury
MicroRNAs
Myocardial Ischemia
Down-Regulation
rosiglitazone
Apoptosis
Caspase 3
Northern Blotting
Cell Survival
Western Blotting
Myocardial Infarction
Cell Proliferation
Pharmacology

Keywords

  • Antagomir
  • Apoptosis
  • Ischaemia-reperfusion injury
  • MiR-29
  • PPAR-γ

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)
  • Physiology
  • Medicine(all)

Cite this

Downregulation of microRNA-29 by antisense inhibitors and a PPAR-γagonist protects against myocardial ischaemia-reperfusion injury. / Ye, Yumei; Hu, Zhaoyong; Lin, Yu; Zhang, Congfang; Perez-Polo, Jose R.

In: Cardiovascular Research, Vol. 87, No. 3, 2010, p. 535-544.

Research output: Contribution to journalArticle

Ye, Yumei ; Hu, Zhaoyong ; Lin, Yu ; Zhang, Congfang ; Perez-Polo, Jose R. / Downregulation of microRNA-29 by antisense inhibitors and a PPAR-γagonist protects against myocardial ischaemia-reperfusion injury. In: Cardiovascular Research. 2010 ; Vol. 87, No. 3. pp. 535-544.
@article{f325ae4315f048f7b9f25ba3f0f28c9e,
title = "Downregulation of microRNA-29 by antisense inhibitors and a PPAR-γagonist protects against myocardial ischaemia-reperfusion injury",
abstract = "AimsMicroRNAs (miRNAs) regulate various cardiac processes including cell proliferation and apoptosis. Pioglitazone (PIO), a peroxisome proliferator-activated receptor (PPAR)-agonist, protects against myocardial ischaemia-reperfusion (IR) injury. We assessed the effects of PPAR-activation on myocardial miRNA levels and the role of miRNAs in IR injury.Methods and resultsWe evaluated the expression changes of miRNAs in the rat heart after PIO administration using miRNA arrays and then confirmed the result by northern blot. miR-29a and c levels decreased remarkably after 7-day treatment with PIO. In H9c2 cells, the effects of PIO and rosiglitazone on miR-29 expression levels were blocked by a selective PPAR-inhibitor GW9662. Downregulation of miR-29 by antisense inhibitor or by PIO protected H9c2 cells from simulated IR injury, indicated as increased cell survival and decreased caspase-3 activity. In contrast, overexpressing miR-29 promoted apoptosis and completely blocked the protective effect of PIO. Antagomirs against miR-29a or-29c significantly reduced myocardial infarct size and apoptosis in hearts subjected to IR injury. Western blot analyses demonstrated that Mcl-2, an anti-apoptotic Bcl-2 family member, was increased by miR-29 inhibition.ConclusionDownregulation of miR-29 protected hearts against IR injury. The modulation of miRNAs can be achieved by pharmacological intervention. These findings provide a rationale for the development of miRNA-based strategies for the attenuation of IR injury.",
keywords = "Antagomir, Apoptosis, Ischaemia-reperfusion injury, MiR-29, PPAR-γ",
author = "Yumei Ye and Zhaoyong Hu and Yu Lin and Congfang Zhang and Perez-Polo, {Jose R.}",
year = "2010",
doi = "10.1093/cvr/cvq053",
language = "English (US)",
volume = "87",
pages = "535--544",
journal = "Cardiovascular Research",
issn = "0008-6363",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Downregulation of microRNA-29 by antisense inhibitors and a PPAR-γagonist protects against myocardial ischaemia-reperfusion injury

AU - Ye, Yumei

AU - Hu, Zhaoyong

AU - Lin, Yu

AU - Zhang, Congfang

AU - Perez-Polo, Jose R.

PY - 2010

Y1 - 2010

N2 - AimsMicroRNAs (miRNAs) regulate various cardiac processes including cell proliferation and apoptosis. Pioglitazone (PIO), a peroxisome proliferator-activated receptor (PPAR)-agonist, protects against myocardial ischaemia-reperfusion (IR) injury. We assessed the effects of PPAR-activation on myocardial miRNA levels and the role of miRNAs in IR injury.Methods and resultsWe evaluated the expression changes of miRNAs in the rat heart after PIO administration using miRNA arrays and then confirmed the result by northern blot. miR-29a and c levels decreased remarkably after 7-day treatment with PIO. In H9c2 cells, the effects of PIO and rosiglitazone on miR-29 expression levels were blocked by a selective PPAR-inhibitor GW9662. Downregulation of miR-29 by antisense inhibitor or by PIO protected H9c2 cells from simulated IR injury, indicated as increased cell survival and decreased caspase-3 activity. In contrast, overexpressing miR-29 promoted apoptosis and completely blocked the protective effect of PIO. Antagomirs against miR-29a or-29c significantly reduced myocardial infarct size and apoptosis in hearts subjected to IR injury. Western blot analyses demonstrated that Mcl-2, an anti-apoptotic Bcl-2 family member, was increased by miR-29 inhibition.ConclusionDownregulation of miR-29 protected hearts against IR injury. The modulation of miRNAs can be achieved by pharmacological intervention. These findings provide a rationale for the development of miRNA-based strategies for the attenuation of IR injury.

AB - AimsMicroRNAs (miRNAs) regulate various cardiac processes including cell proliferation and apoptosis. Pioglitazone (PIO), a peroxisome proliferator-activated receptor (PPAR)-agonist, protects against myocardial ischaemia-reperfusion (IR) injury. We assessed the effects of PPAR-activation on myocardial miRNA levels and the role of miRNAs in IR injury.Methods and resultsWe evaluated the expression changes of miRNAs in the rat heart after PIO administration using miRNA arrays and then confirmed the result by northern blot. miR-29a and c levels decreased remarkably after 7-day treatment with PIO. In H9c2 cells, the effects of PIO and rosiglitazone on miR-29 expression levels were blocked by a selective PPAR-inhibitor GW9662. Downregulation of miR-29 by antisense inhibitor or by PIO protected H9c2 cells from simulated IR injury, indicated as increased cell survival and decreased caspase-3 activity. In contrast, overexpressing miR-29 promoted apoptosis and completely blocked the protective effect of PIO. Antagomirs against miR-29a or-29c significantly reduced myocardial infarct size and apoptosis in hearts subjected to IR injury. Western blot analyses demonstrated that Mcl-2, an anti-apoptotic Bcl-2 family member, was increased by miR-29 inhibition.ConclusionDownregulation of miR-29 protected hearts against IR injury. The modulation of miRNAs can be achieved by pharmacological intervention. These findings provide a rationale for the development of miRNA-based strategies for the attenuation of IR injury.

KW - Antagomir

KW - Apoptosis

KW - Ischaemia-reperfusion injury

KW - MiR-29

KW - PPAR-γ

UR - http://www.scopus.com/inward/record.url?scp=77954766181&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954766181&partnerID=8YFLogxK

U2 - 10.1093/cvr/cvq053

DO - 10.1093/cvr/cvq053

M3 - Article

VL - 87

SP - 535

EP - 544

JO - Cardiovascular Research

JF - Cardiovascular Research

SN - 0008-6363

IS - 3

ER -